Regeneron Pharma (REGN) PT Lowered to $180 at Wells Fargo
Tweet
Share
E-mailGet Alerts REGN Hot Sheet
Price: $827.72 -1.87%
Rating Summary:
29 Buy, 19 Hold, 0 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 9 | Down: 7 | New: 5
Rating Summary:
29 Buy, 19 Hold, 0 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 9 | Down: 7 | New: 5
Join SI Premium – FREE
Wells Fargo analyst Brandon Couillard lowered the price target on Regeneron Pharma (NASDAQ: REGN) to $180.00 (from $190.00) while maintaining a Overweight rating.
You May Also Be Interested In
- RBC Capital Reiterates Sector Perform Rating on Regeneron Pharma (REGN)
- Phreesia Inc. (PHR) PT Lowered to $13 at DA Davidson
- Equity Bancshares (EQBK) PT Raised to $59 at StoneX
Create E-mail Alert Related Categories
Analyst PT ChangeSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
